90% — Will Marty Makary be out as FDA commissioner before Jun 1, 2026
Leader: Before Jul 1, 2026 at 90% · Kalshi 90% · 4 contracts · $40K volume · medium confidence
Updated 2026-05-09 04:21:01 UTC

Tracks the leading outcome in a winner-take-all prediction market set with 4 outcomes.

Why this matters:
Markets are assigning a 69% probability that Marty Makary will exit his role as FDA commissioner by January 1, 2027, though only a 19% probability he leaves by June 1, 2026. The wide gap between the near-term and longer-term contracts suggests traders expect stability through early summer but increasing pressure or departures as 2026 progresses. FDA commissioners typically serve multi-year terms, making sudden departures relatively uncommon absent major conflicts or administrative changes. The probability reflects uncertainty around Makary's relationship with the administration, potential policy disputes, or broader cabinet turnover. Key catalysts would include formal resignation announcements, major regulatory controversies, or congressional actions, though no specific near-term event appears imminent based on contract pricing.

Key factors:
- FDA commissioner tenure typically spans years; contracts pricing 19% departure risk by June 1 suggests markets view imminent exit as unlikely despite 69% longer-term probability
- The steep pricing curve (19¢→34¢→54¢→69¢ across Jun/Jul/Aug/Jan contracts) indicates traders expect uncertainty to increase later in 2026 rather than resolve quickly
- Makary took office in 2023 and remains active in the role as of May 2026, with no recent public reporting of significant health or administrative crises triggering departures
- FDA commissioners historically depart through planned retirements, completion of terms, or major policy conflicts—contract pricing suggests markets assign meaningful probability to one of these scenarios by year-end 2026
- Trading volume is modest ($24 on nearest contract), indicating limited institutional conviction and potential for price movement if new information emerges about administration stability or personnel decisions

Contracts:
- Will Marty Makary be out as FDA commissioner before Jul 1, 2026?: Before Jul 1, 2026 — 90¢ Kalshi $7K (weight 17%)
- Will Marty Makary be out as FDA commissioner before Jan 1, 2027?: Before Jan 1, 2027 — 89¢ Kalshi $5K (weight 12%)
- Will Marty Makary be out as FDA commissioner before Aug 1, 2026?: Before Aug 1, 2026 — 86¢ Kalshi $4K (weight 10%)
- Will Marty Makary be out as FDA commissioner before Jun 1, 2026?: Before Jun 1, 2026 — 73¢ Kalshi $24K (weight 61%)

Cite as: "90% per prediction markets (SimpleFunctions, May 2026)"
Canonical: https://simplefunctions.dev/answer/makaryout
Full data: https://simplefunctions.dev/api/public/query?q=Will%20Marty%20Makary%20be%20out%20as%20FDA%20commissioner%20before%20Jun%201%2C%202026
Provider: SimpleFunctions — https://simplefunctions.dev